EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Physicochemical Comparison of Kolliphor HS 15, ELP, and Conventional Surfactants for Antibody Stabilization in Biopharmaceutical Formulations

Nadine Löw, Coralie Schneider iD, Maksymilian Marek Zegota iD, Adam Grabarek, Eleonora Corradini, Georg Schuster, Meike Maria Roskamp, Felicitas Guth, Andrea Hawe, Matthias Kellermeier iD

Molecular Pharmaceutics · 04.08.2025 · 22 (8) · 4890-4908

DOI: 10.1021/acs.molpharmaceut.5c00519 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Molecular Pharmaceutics, online erschienen am 27.06.2025. Verfasst von Nadine Löw und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pharma Solutions, BASF SE, G-ENP/MD - H201, Carl-Bosch-Strasse 38, D-67056 Ludwigshafen, Germany. Hauptthemen laut MEDLINE: Surface-Active Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stabilization of therapeutic protein formulations with nonionic surfactants such as Polysorbate 20 (PS20), Polysorbate 80 (PS80), or Poloxamer 188 (P188) is imperative to avoid critical loss of the active pharmaceutical ingredient by aggregation or adsorption onto different types of interfaces. In the present work, we have characterized the interfacial activity of the aforementioned surfactants, alone and in competition with antibodies, in comparison to two other excipients with approval for use in parenteral applications, Kolliphor HS 15 (HS15) and Kolliphor ELP (ELP). To this end, we applied a comprehensive suite of experimental techniques, including tensiometry, interfacial rheology, and quartz-crystal microbalance with dissipation monitoring (QCM-D). The obtained data shows important differences between the surfactants as well as a clear influence of the type of interface considered on the observed behavior. In order to link these physicochemical results to the performance of the chosen surfactants in the stabilization of antibodies, we performed another series of tests to quantify protein aggregation (i.e., the formation of (sub)visible particles in formulations under stress) as well as the release of oil from siliconized vials. In addition, the stability of the surfactants against enzymatic degradation was investigated. It is demonstrated that HS15 can compete with the widely used polysorbates in terms of interfacial activity and protein stabilization, while offering higher robustness against degradation by a lipase and an esterase. On the other hand, P188 shows poor interfacial activity but can still suppress the aggregation of at least some proteins, indicating that different mechanisms of stabilization are at play. Our findings and the broad spectrum of tests described in this work are instructive toward a better understanding of protein stabilization in distinct primary packaging systems through surfactants in aqueous formulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Surface-Active AgentsExcipientsPolysorbatesDrug CompoundingPoloxamerChemistry, PharmaceuticalProtein StabilityProtein AggregatesRheologyAntibodies, Monoclonal

Stichwörter der Autor:innen

antibodiescontainer closurequartz-crystal microbalancesurface activitysurfactants

Substanzen

Surface-Active AgentsExcipientsPolysorbatesPoloxamerProtein AggregatesAntibodies, Monoclonal

Autor:innen und Institutionen

  • Pharma Solutions, BASF SE, G-ENP/MD - H201, Carl-Bosch-Strasse 38, D-67056 Ludwigshafen, Germany.
  • Material Science, BASF SE, RGS/BP - B007, Carl-Bosch-Strasse 38, D-67056 Ludwigshafen, Germany.
  • Coriolis Pharma Research, Fraunhoferstraße 18B, D-82152 Martinsried, Germany.

ORCID-Profile: Coralie Schneider, Maksymilian Marek Zegota, Matthias Kellermeier

Zitieren

APA

Löw, N., Schneider, C., Zegota, M. M., Grabarek, A., Corradini, E., Schuster, G., Roskamp, M. M., Guth, F., Hawe, A., & Kellermeier, M. (2025). Physicochemical Comparison of Kolliphor HS 15, ELP, and Conventional Surfactants for Antibody Stabilization in Biopharmaceutical Formulations. Molecular Pharmaceutics, 22(8), 4890-4908. https://doi.org/10.1021/acs.molpharmaceut.5c00519

Vancouver

Löw N, Schneider C, Zegota MM, Grabarek A, Corradini E, Schuster G, et al. Physicochemical Comparison of Kolliphor HS 15, ELP, and Conventional Surfactants for Antibody Stabilization in Biopharmaceutical Formulations. Molecular Pharmaceutics. 2025;22(8):4890-4908. doi:10.1021/acs.molpharmaceut.5c00519

BibTeX
@article{Lw2025,
  author = {Löw, Nadine and Schneider, Coralie and Zegota, Maksymilian Marek and Grabarek, Adam and Corradini, Eleonora and Schuster, Georg and Roskamp, Meike Maria and Guth, Felicitas and Hawe, Andrea and Kellermeier, Matthias},
  title = {Physicochemical Comparison of Kolliphor HS 15, ELP, and Conventional Surfactants for Antibody Stabilization in Biopharmaceutical Formulations},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  volume = {22},
  number = {8},
  pages = {4890--4908},
  doi = {10.1021/acs.molpharmaceut.5c00519}
}
Kostenlos starten →